Hiroyuki Kitao

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 8

Top Venues

Cancer science

Molecular cancer research : MCR

Scientific reports

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tomoharu Mori, Yusuke Okamoto, Anfeng Mu, Yoshimi Ide, Akiyo Yoshimura, Noriko Senda, Yukiko Inagaki-Kawata, Masahiro Kawashima, Hiroyuki Kitao, Eriko Tokunaga, Yasuo Miyoshi, Shozo Ohsumi, Koichiro Tsugawa, Tomohiko Ohta, Toyomasa Katagiri, Shigeru Ohtsuru, Kaoru Koike, Seishi Ogawa, Masakazu Toi, Hiroji Iwata, Seigo Nakamura, Keitaro Matsuo, Minoru Takata
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers. Cancer medicine (2022)
Shichao Qiu, Makoto Iimori, Keitaro Edahiro, Yoshiaki Fujimoto, Kazuaki Matsuoka, Eiji Oki, Yoshihiko Maehara, Masaki Mori, Hiroyuki Kitao
CD44v3,8-10 is essential for Slug-dependent vimentin gene expression to acquire TGF-β1-induced tumor cell motility. Cancer science 113 (8) (2022)
Yoshiaki Fujimoto, Eiji Oki, Shichao Qiu, Ryota Nakanishi, Akitaka Makiyama, Yuji Miyamoto, Masahito Kotaka, Mototsugu Shimokawa, Koji Ando, Yasue Kimura, Hiroyuki Kitao, Yoshihiko Maehara, Masaki Mori
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatment. Cancer science 112 (6) (2021)
Yuki Kataoka, Makoto Iimori, Ryo Fujisawa, Tomomi Morikawa-Ichinose, Shinichiro Niimi, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Daisuke Miura, Toshiki Tsurimoto, Yoshihiko Maehara, Hiroyuki Kitao
DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status. Molecular cancer research : MCR 18 (9) (2020)
Yuki Kataoka, Makoto Iimori, Shinichiro Niimi, Hiroshi Tsukihara, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Hiroyuki Kitao
Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level. Scientific reports 9 (1) (2019)
Keitaro Edahiro, Makoto Iimori, Takashi Kobunai, Tomomi Morikawa-Ichinose, Daisuke Miura, Yuki Kataoka, Shinichiro Niimi, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Hiroyuki Kitao, Yoshihiko Maehara
Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity. Molecular cancer research : MCR 16 (10) (2018)
Sugiko Watanabe, Makoto Iimori, David Virya Chen, Eiji Hara, Hiroyuki Kitao, Yoshihiko Maehara
MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites. Scientific reports 8 (1) (2018)
Hiroyuki Kitao, Makoto Iimori, Yuki Kataoka, Takeshi Wakasa, Eriko Tokunaga, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara
DNA replication stress and cancer chemotherapy. Cancer science 109 (2) (2017)

Hiroyuki Kitao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroyuki Kitao